Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 July 1999

Effect of application of n-3 polyunsaturated fatty acids on blood serum concentration of von Willebrand factor in type II diabetes mellitus

Peter Hab‡an, Robert Simoncic, Jana Klvanova, Eva Zidekova

Med Sci Monit 1999; 5(4): CR661-665 :: ID: 503471

Abstract

Increased concentration of von Willebrand factor (vWF) is generally accepted as independent risk factor for cardiovascular complications in type 2 diabetes. In attempt to decrease its blood serum concentration, 34 patients with type 2 diabetes mellitus were supplemented for 28 days with 1.7 g of eicosapentaenoic acid (EPA) plus 1.15 g docosahexaenoic acid (DHA)per each day, followed by a 3 months' wash-out control period with20 patients. After the period of supplementation with EPA and DHA, there was a significant decline in vWF by 15.66 % of ref. plasma (95% CI 6.13, 25.19) followed by its significant increase during the wash-out (on average by 19.15 %; 95% CI 1.24, 37.06). Changes in vWF (DvWF) after intervention correlated with vWF baseline values (r=Ð0.415; p=0.015) and during the entire follow-up (intervention + wash-out) also inversely with changes in EPA, DHA and 22: 5n3 (docosapentaenoic acid) in serum phospholipids (r=Ð0.409, r=-0.454, r=-0.418; p=0.002, p=0.0006, p=0.002, respectively). Supplementation with long-chain n-3 PUFAs (incl. EPA and DHA) in this indication seems to be beneficial also because of its other effects, e. g. on lipoprotein and eicosanoid spectrum, blood rheology etc.

Keywords: n-3 fatty acids, von Willebrand Factor, type 2 diabetes

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750